Related Experiment Video

Updated: Jun 13, 2026

Generation of Murine Cardiac Pacemaker Cell Aggregates Based on ES-Cell-Programming in Combination with Myh6-Promoter-Selection
08:52

Generation of Murine Cardiac Pacemaker Cell Aggregates Based on ES-Cell-Programming in Combination with Myh6-Promoter-Selection

Published on: February 17, 2015

Pitx2 prevents susceptibility to atrial arrhythmias by inhibiting left-sided pacemaker specification

Jun Wang1, Elzbieta Klysik, Subeena Sood

  • 1Institute of Biosciences and Technology, Texas A&M System Health Science Center, Houston, TX 77030, USA.

Proceedings of the National Academy of Sciences of the United States of America
|May 12, 2010
PubMed

Insights

Pitx2 gene deficiency in mice leads to atrial arrhythmias like atrial fibrillation. This suggests Pitx2-mediated pathways are crucial for preventing these heart rhythm disorders.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Genetics

Background:

  • Atrial fibrillation (AF) and atrial flutter (AFL) are common cardiac arrhythmias.
  • Current therapies for AF and AFL have limitations, necessitating a deeper understanding of their molecular mechanisms.
  • Genetic studies have linked chromosome 4q25 variants to familial AF and AFL, near the developmental gene Pitx2.

Purpose of the Study:

  • To investigate the role of the Pitx2 gene in atrial arrhythmogenesis using mouse models.
  • To determine if Pitx2 deficiency predisposes to atrial arrhythmias.
  • To elucidate the molecular mechanisms by which Pitx2 influences atrial electrophysiology.

Main Methods:

  • Utilized Pitx2 haploinsufficient (Pitx2(null+/-)) adult mice.
  • Challenged mice with programmed electrical stimulation to induce arrhythmias.
  • Employed microarray and in situ hybridization to study gene expression.
  • Conducted in vivo ChIP and transfection assays to assess Pitx2-Shox2 interactions.

Main Results:

  • Pitx2 haploinsufficiency resulted in atrial arrhythmias, including AFL and atrial tachycardia, in adult mice.
  • Pitx2 was found to suppress sinoatrial node (SAN)-specific gene expression, such as Shox2, in the left atrium.
  • Pitx2 directly binds to and inhibits the SAN-specific genetic program in the left atrium.

Conclusions:

  • Pitx2 plays a critical role in preventing atrial arrhythmias.
  • Pitx2-mediated left-right asymmetry (LRA) signaling pathways are implicated in the prevention of atrial arrhythmias.
  • These findings highlight Pitx2 as a potential therapeutic target for atrial arrhythmias.

More Related Videos

Microelectrode Array Recording of Sinoatrial Node Firing Rate to Identify Intrinsic Cardiac Pacemaking Defects in Mice09:20

Microelectrode Array Recording of Sinoatrial Node Firing Rate to Identify Intrinsic Cardiac Pacemaking Defects in Mice

Published on: July 5, 2021

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Electrophysiology of Normal Cardiac Rhythm01:19

Electrophysiology of Normal Cardiac Rhythm

The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase of...
Conduction System of the Heart01:19

Conduction System of the Heart

Autorhythmicity is a term that refers to the heart's inherent ability to generate electrical signals and instigate muscle contractions. This self-regulating conduction system within the heart consists of two key components: the pacemaker cells and specialized conducting cells.
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...